Mineralys Therapeutics (MLYS) Earnings Date, Estimates & Call Transcripts → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free MLYS Stock Alerts $12.78 -0.06 (-0.47%) (As of 03/27/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 20EstimatedActual EPS (Mar. 21) -$0.61 Beat By $0.24 Consensus EPS (Mar. 21) -$0.85 Read Call TranscriptListen to Call Get Mineralys Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for MLYS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMLYS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MLYS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Mineralys Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.64) EPSNext Year EPS Consensus Estimate: ($3.34) EPSMLYS Earnings Date and InformationMineralys Therapeutics last posted its earnings results on March 21st, 2024. The reported ($0.61) EPS for the quarter, topping the consensus estimate of ($0.85) by $0.24. Mineralys Therapeutics has generated ($2.00) earnings per share over the last year (($2.00) diluted earnings per share). Earnings for Mineralys Therapeutics are expected to decrease in the coming year, from ($2.64) to ($3.34) per share. Mineralys Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More Mineralys Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 3/21/2024Q4 2023($0.85)($0.61)+$0.24($0.61)-- 11/7/2023Q3 2023($0.72)($0.57)+$0.15($0.57)--8/7/2023Q2 2023($0.83)($0.31)+$0.52($0.31)--5/15/2023Q1 2023($0.71)($0.51)+$0.20($0.51)--3/15/2023Q4 2022-($1.74)($1.74)($1.74)-- Mineralys Therapeutics Earnings - Frequently Asked Questions When is Mineralys Therapeutics's earnings date? Mineralys Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on MLYS's earnings history. Did Mineralys Therapeutics beat their earnings estimates last quarter? In the previous quarter, Mineralys Therapeutics (NASDAQ:MLYS) reported ($0.61) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.24. Learn more on analysts' earnings estimate vs. MLYS's actual earnings. How can I listen to Mineralys Therapeutics's earnings conference call? The conference call for Mineralys Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Mineralys Therapeutics's conference call transcript? The conference call transcript for Mineralys Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Mineralys Therapeutics generate each year? Mineralys Therapeutics (NASDAQ:MLYS) has a recorded net income of -$71.90 million. MLYS has generated -$2.00 earnings per share over the last four quarters. What is Mineralys Therapeutics's EPS forecast for next year? Mineralys Therapeutics's earnings are expected to decrease from ($2.64) per share to ($3.34) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BMEA Earnings Date GHRS Earnings Date TVTX Earnings Date ALXO Earnings Date IGMS Earnings Date CMPS Earnings Date SIGA Earnings Date NKTX Earnings Date MRNS Earnings Date MRSN Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:MLYS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.